EDUCATION:
| Ph.D. |
|
Bio-organic
Chemistry, Indian Institute of Technology, Bombay
(1985) |
| M.S. |
|
Chemistry,
Indian Institute of Technology, Bombay (1980) |
|
EXPERIENCE:
|
CURRENT
POSITION
(Jun. 2007 - present) |
|
Senior
Consultant Biologics Consulting Group Inc.
Plainsboro, NJ. |
| |
|
|
| 2006
- May 2007 |
|
Senior
Manager, Quality Control, Sun Pharmaceutical Industries
Inc.
Cranbury NJ.
- Managed
the QC department with 20 people in the validation
and cGMP testing groups to support R&D regulatory
submission and commercial operations.
- Established
the cGMP systems based on Corporate Quality guidelines
to prepare the laboratory for the first FDA inspection.
- Established
the equipment qualification master plan, upgraded
the stability program to current industry standards
|
| |
|
|
| 2003
- 2005 |
|
Manager,
Stability, Sandoz (Novartis)
Dayton, NJ.
- Managed
a group of 7 chemists and 3 sample coordinators /stability
administration personnel for the Research and Commercial
Stability Program. Responsibilities included stability
storage and testing, sample flow, controlled drug
substances and Reference Standards.
- Recognized
for significantly improving the cGMP compliance of
the stability program, the sample flow system to facilitate
testing metrics reporting.
- Improved
communication in the company by flow charting processes,
obtaining buy-in from other functional groups to improve
sample flow from manufacturing into the lab and information
out to Regulatory.
|
| |
|
|
| 2001
- 2003 |
|
Principal
Scientist (Group Leader, Stability Management),
Pfizer
St. Louis, MO.
- Managed
a team of stability administrators and CMC documentation
personnel for the Biologics Stability Program.
- Set
up the cGMP systems required for the Commercial and
R&D Biopharma Stability Program involving several
contract facilities and Pfizer internal laboratories.
- Led
a team of Engineers and Project Managers to construct
and validate a state-of-the-art cGMP Stability Facility,
completed on time and within budget.
|
| |
|
|
| 1998
- 2001 |
|
Supervisor,
Bioprocess QC, Monsanto Company
St. Louis, MO.
- Managed
a team of 4 chemists in the General and Electrochemistry
laboratories.
- Responsibilities
included optimization and validation of analytical
methods for the QC laboratory and release/stability
testing of cGMP lots.
|
| |
|
|
| Mar.
1998 - Jul. 1998 |
|
Scientist,
Bioprocess QC, Monsanto Company
St. Louis, MO.
- Participated
in the team to set up cGMP systems for the new Biologics
QC laboratory. Responsible for the electrophoresis
laboratory.
- Designed
a composite worksheet system for recording raw data.
Presented worksheet system at Industry meeting with
positive response.
- Designed
and implemented validated spreadsheets for performing
calculations in the Bioprocess Analytical laboratory.
|
| |
|
|
| Feb.
1995 - Feb. 1998 |
|
QA
Methods Validation Specialist, Organics LaGrange
Northbrook, IL.
- Responsible
for method validation and oversight of QC lab cGMP
compliance.
- Optimized
analytical methods for commercial QC lab.
- Served
as company's technical contact with USP.
- Tripled
the laboratory capacity by implementing chromatography
system automation.
- This
project impacted virtually every group in the
company, was completed on time, within allotted
resources and performed error free after implementation.
|
| |
|
|
| 1987
- 1995 |
|
Post
Doctoral Biochemist, Northwestern University
Evanston IL.
- Interaction
of proteins and peptides with liposomes and other
lipid preparations. Protein and peptide conformation
studies. Hands on experience in protein and peptide
purification, synthetic organic chemistry, analytical
techniques for amino acids, peptides and proteins,
Circular dichroism, NMR, Fluorescence and other spectroscopic
techniques.
|
| |
|
|
| 1985
- 1987 |
|
Post
Doctoral Biochemist, University of California at
San Francisco
San Francisco, CA.
- Interaction
of peptides with liposomes and other lipid preparations.
Protein and peptide conformation studies. Hands on
experience in peptide synthesis and purification,
analytical techniques for peptides, Circular dichroism,
NMR, IR and other spectroscopic techniques.
|
| CONTINUING
EDUCATION |
- Obtained
training in subjects such as Certified Quality Auditor,
Audit Preparation, cGMP Compliance, Project Management
and Negotiation skills.
|
|
| INVITED
PRESENTATIONS |
| 1) |
Understanding
the effects of Global Regulations and Markets on Stability
Programs" CBI's Stability Programs Conference, June
7-8, Princeton NJ. |
| 2) |
"Design
and Implementation of a worksheet system to record lab
data". Barnett International conference on 'Laboratory
Notebooks -- Paper and Electronic, Renaissance Hotel,
May 10-11, 2001, Washington DC. |
| 3) |
"Stability
Facility GXP Compliance - Early Tox to Phase III Clinical
Studies", IBC's 3rd International Conference on Formulation
Strategies for Biopharmaceuticals, September 22-24, 2003,
Philadelphia PA. |
| 4) |
Taught
the 2 day PTI course, "How to design and Implement
Effective Stability Programs for Biotechnology Products".
July 2003, Bostom, MA. |
| 5) |
"Stability
Assessment in Biotechnology Product Protocols", 6th
Annual Stability Testing Forum, July 15-16, 2004, Philadelphia
PA. |
| 6) |
"Handling
OOS and OOT results", IVT's conference on Stability
Testing, November 29-December 2, 2005, Amsterdam, The
Netherlands. |
| 7) |
Work
shop on 'Handling OOS and OOT in the Laboratory during
Stability Studies', IVT's conference on Stability Testing,
November 29-December 2, 2005, Amsterdam, The Netherlands. |
| 8) |
"Effective
Implementation of Stability Program", IPA's Stability
Program conference, Feb 20-21, 2006, Toronto, Canada. |
| 9) |
Workshop on "Handling Stability OOS and OOT Results"
IPA's Stability Program conference, Feb 20-21, 2006, Toronto,
Canada. |
| 10) |
Moderator
for the Regulatory Panel Discussion, "Design and
Structure of Formal Stability/Accelerated Stability Studies"
IIRUSA Conference on Formulation and Forced Degradation
for Biopharmaceuticals March 27-29, 2006, San Francisco,
CA. |
Page
Updated
August 20, 2008
|